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ABSTRACT 
Alcoholic liver disease (ALD) is a leading cause of morbidity and mortality in India. Chronic consumption 
of alcohol results in variations in alcohol metabolism, oxidative stress, antigenic adducts formation and 
acetaldehyde toxicity. These factors cause inflammation, fatty changes, fibrosis of liver cells and raising the 
transaminases in the blood. There is no specific treatment for ALD.  
Vasaguduchyadi Kashayam is a classical Ayurvedic formulation stated in Ashtanga Hridayam for the 
treatment of Jaundice and anemia. The study focuses on the effect of the Vasaguduchyadi Kashayam in ALD 
for restoration of normal liver function, with the help of investigating 10 subjective and 2 objective 
parameters. As the Vasaguduchyadi Kashayam is Yakritgami, Kamalanashak and Pandunashak, was used as 
Trial Drug.  
Clinical Trials were conducted at Anandvan De-Addiction Centre, Pune. By ballot method 60 well 
diagnosed male patients of ALD were included in both Control and Trial group each. The diagnosis of ALD 
was made by documentation of alcohol excess and evidence of liver disease.  
The control group was allowed to partake symptomatic line of treatment advised by the centre while the 
trial group was administered Vasaguduchyadi kashayam in a dose of 15ml with luke warm water after 
meal for the duration of 45 days. Patients of both groups followed complete abstinence from Alcohol and 
Pathyakar aahar-vihar. 
The statistical analysis revealed that Trial drug is effective in ALD. It significantly reduces Agnimandya, 
Aruchi, Hrillas, Trishna Pitatva and LFT. 
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INTRODUCTION
Alcohol consumption accounts for 5.9 % of all 
deaths worldwide[1] and is the prime cause of Alcoholic 
Liver Disease (ALD). This is characterized by macro or 
micro vesicular fatty changes, diffuse or massive necrosis, 
acute or chronic hepatitis, fibrosis and liver cirrhosis as 
also its malfunctioning[2].  
The primary metabolite of alcohol i.e. 
Acetaldehyde is thought to be a major cause of alcoholic 
liver disease. Acetaldehyde impairs mitochondrial 
oxidative system resulting in variations in alcohol 
metabolism, centrilobular hypoxia; inflammatory cell 
infiltration and activation, antigenic adducts formation, 
reactive oxygen species formation and lipid 
peroxidation[2,3,4,5]. These factors cause inflammation, fatty 
changes, fibrosis of liver cells. The range of clinical features 
of alcoholic liver disease varies, from asymptomatic to 
end-stage liver disease with portal hypertension, jaundice 
and encephalopathy Patients may present symptoms such 
as nausea, anorexia, fever, ascites and jaundice[5]. A 
number of laboratory abnormalities, including elevated 
AST and ALT have been reported in patients with ALD, and 
used to diagnose ALD[6]. 
The symptoms of ALD often improve with the 
cessation of drinking. Immediate and total abstinence from 
alcohol is critical for patients with alcoholic liver disease. 
Continued drinking is associated with disease progression, 
while abstinence benefits patients at any stage of disease. 
There is no specific treatment for ALD.  
 Contemporary management of the condition too 
promotes the use of hepato-protective herbal or herbo-
mineral formulations. The current study is thus an 
endeavor to establish the efficacy of herbal formulation 
viz. Vasaguduchyadi kashayam quoted by 
Vagbhatacharya[7]. 
AIM AND OBJECTIVES 
 The study was conducted with the aim to assess 
the effect of Vasaguduchyadi kashayam in ALD. The 
objective was to ascertain the restoration of normal liver 
functions. 
MATERIALS AND METHOD 
 The trial drug, Vasaguduchyadi kashayam was 
purchased from Arya Vaidya Sala Kottakal, Kerala- a 
standardized licensed Pharmacy (Batch No.508711). The 
Vasaguduchyadi kashayam used was as per the reference 
of Ashtanga Hridayam[7].  
This Open Randomized Clinical Trial was 
conducted at Anandvan De-addiction and Rehabilitation 
Centre, Chandan Nagar, Pune, India after the permission of 
the Institutional Ethics Committee (Vide letter no: 
BVDU/COA/1680-2/2012-13).  
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Source of data: For the study well diagnosed patients of 
ALD were randomly selected from the in-patient 
departments of Anandvan De-addiction and Rehabilitation 
Centre, Chandan Nagar, Pune, India. 
Method of collection of data:  
 Detailed clinical history and clinical examination 
was carried out before assessing the case and starting the 
proper trial. The diagnosis of ALD was made by 
documentation of alcohol excess and evidence of liver 
disease using the special proforma. Clinically diagnosed 
patients of ALD were selected and randomly allotted to 
either of 2 group’s viz. Trial or Control by ballot method 
after taking Informed Consent. The criteria of inclusion 
were patients suffering from ALD, sex male only of the age 
group of 18 to 60 years. Patients suffering from Non 
Alcoholic Liver Disease, Infective Hepatitis, Hypertension 
and other high risk conditions were exclude from the 
study. 
 A sample size of 60 patients was decided upon 
considering the incidence of the condition of the place of 
study and time duration. A total of 94 patients were 
screened and 72 of them were enrolled in the study, but a 
dropout of 12 was registered. All patients were subjected 
to pre and post laboratory tests of Haemogram and Liver 
Function Test (LFT). 
Dosage: The Trial Group patients were administered 15 
ml of Vasaguduchyadi kashayam two times a day after 
meals with luke warm water for 45 days. Patients of the 
Control Group did not receive any trial drug but followed 
symptomatic treatment as and when required. 
Duration of study: The duration of study was 45 days. 
Follow up: All patients, who were included in study, were 
studied daily for 45 days. 
Inclusion Criteria:  
a) Clinically diagnosed patients of Alcoholic Liver Disease 
were selected. 
b) Age group – above 18 years (as patients below this 
category were negligible in the centre).  
c) Sex –Male (as female were not admitted in this 
particular centre).  
Exclusion Criteria  
a. Age below 18 years  
b. Sex –Female  
c. Patients suffering from non alcoholic hepatitis 
d. Patients with high risk diseases and severe illness  
e. Patients who are diagnosed as Liver cirrhosis, Hepatic 
coma, Ascites, Portal hypertension, Spleenomegaly, 
Hepatocellular carcinoma etc.  
Assessment Criteria 
 The A pilot study was conducted before the 
commencement of the actual trial so as to define criteria of 
assessment. On the basis of this, 10 subjective parameters 
viz. Agnimandya (Loss of appetite), Aruchi (Tastelessness), 
Hrillas (Nausea), Trishna (Thirst), Manda Jwara (Mild 
fever), Daha (Burning sensation all over the body), 
Panduta (Pallor), Pitatva of Nakh-Netra-Twak_Mala 
(Icterus), Daurbalya (Weakness) and Bhrama (Vertigo) 
formed the criteria of Assessment on enrolment and 
weekly follow ups.  
 These parameters were graded on the basis of 
CTCAE guidelines of 2009. Haemogram and LFT formed 
the objective parameters. 
Subjective Parameters 
1. Assessment of Agnimandya (Loss of Appetite) 
0 : Absent 
1 : Present 
2. Assessment of Aruchi (Tastelessness) 
0 : Absent 
1 : Present 
3. Assessment of Hrillas (Nausea) 
0 : Absent 
1 : Nausea 
2 : Nausea with excess salivation 
3 : Nausea with regurgitation 
4 : Nausea with vomiting 
4. Assessment of Trishna (Thirst) 
0 : Absent 
1 : Mild 
2 : Moderate 
3 : Sever but reduces after water intake 
4 : Sever but don’t reduces after water intake 
5. Assessment of Manda Jwara (Mild Fever) 
0 : Absent 
1 : Present 
6. Assessment of Daha (Burning sensation) 
0 : Absent 
1 : Present 
7. Assessment of Panduta (Pallor) 
0 : Absent 
1 : Present 
8. Assessment of Pitatva (Icterus) 
0 : Absent 
1 : Present 
9. Assessment of Daurbalya (Weakness) 
0 : Absent  
1 : Dyspnoea after moderate to severe work  
2 : Dyspnoea after mild to moderate work 
3 : Dyspnoea after mild work  
4 : Dyspnoea at rest 
10. Assessment of Bhrama (Vertigo) 
0 : Absent  
1 : Occasionally  
2 : Frequently 
3 : Often and with short disorientation  
4 : More often and with prolonged disorientation 
Objective Parameters 
1. Haemogram 
2. Liver Function Test 
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Statistical Analysis 
The Wilcoxon Paired Signed Rank test was carried 
out for each of the assessment criterion separately to 
assess efficacy. The Mann Whitney ‘u’ test was run 
separately for each criterion to compare the efficacy 
between the Trial and Control groups. 
Statistical analysis was carried out in terms of 
Mann‐Whitney U test; z-test and finally results were 
incorporated in term of probability (p). 
RESULTS 
Table 1: Showing effect on subjective parameters between Trial and Control group 
  Agnimandya Aruchi Hrillas Trishna Daha 
Pitatva of Nakh Netra 
Twak and Mala 
Daurbalya Bhrama 
Mann-
Whitney U 
183.000 271.50 228.000 443.000 427.000 57.000 319.000 383.00 
Z -4.212 -2.876 -3.459 -.109 -.412 -6.186 -2.080 -1.228 
p-value .000 .004 .001 .913 .680 .000 .038 .219 
 8 out of the pre-defined 10 subjective parameters were predominantly observed in both groups. From the above 
table it is observed that there is no significant difference in two groups for Trishna, Daha and Bhrama as p- value Mann- 
Whitney U test is greater than 0.05. While significant difference is observed in two groups for Agnimandya, Aruchi, Hrillas, 
Pitatva and Daurbalya. 
Table 2: Showing effect on objective parameters between Trial and Control group 
  
  95% C.I. 
t p-value Result 
df 
Mean 
Difference 
Std. Error 
Difference 
Lower Upper 
Hemoglobin 58 .49000 .16514 .15943 .82057 2.967 .001 Significant 
S.G.P.T. 58 43.91000 6.91793 30.06226 57.75774 6.347 .000 Significant 
S.G.O.T. 58 63.87333 9.23149 45.39450 82.35217 6.919 .000 Significant 
Alkaline Phosphatase 58 74.40667 13.96333 46.45603 102.35731 5.329 .033 Significant 
Total Bilirubin 58 .82100 .17793 .46484 1.17716 4.614 .000 Significant 
Direct Bilirubin 58 .44833 .11159 .22495 .67171 4.018 .000 Significant 
Indirect Bilirubin 58 .31400 .09966 .11452 .51348 3.151 .001 Significant 
OBSERVATIONS & RESULTS 
 Based on the statistical analysis, the effects of the 
drug on various parameters were studied and following 
results were obtained. 
Agnimandya showed 100% relief in Trial group 
and 29.27% in control group [Fig.1]. Aruchi recorded an 
alleviation of 100% in trial group whereas the control 
group showed only 27.27% alleviation [Fig.2]. Hrillas was 
reduced by 100% of the patients of trial group as 
compared to 61.84% in Control group [Fig.3] 
 Trishna was reduced by 100% of the patients of 
trial group as compared to 72.41% in Control group 
[Fig.4]. The symptom of Daha showed 92.31% reduction in 
the trial group and an 80% reduction in control group 
[Fig.5]. Pitatva was reduced by 100% of the patients of 
trial group as compared to 17.95% in Control group 
[Fig.6]. 
Daurbalya was reduced by 66.67% of the patients 
of trial group as compared to 57.63% in Control group 
[Fig.7]. Similarly, Bhrama recorded an alleviation of 
83.33% in trial group whereas the control group showed 
only 73.08% alleviation [Fig.8].  
The objective parameters viz. LFT was normalized 
and an elevation in the Haemoglobin % was also noted. (p-
value< 0.001). 
DISCUSSION 
Vasaguduchyadi kashayam is a combination of 6 
herbal ingredients[3] viz. Vasa (Adathoda vasica), Guduchi 
(Tinospora cordifolia), Triphala (Emblica offcinalis, 
Terminalia bellerica, Terminalia chebula), Kutaki 
(Picrorrhiza kurroa), Bhunimba (Andrographis paniculata) 
and Nimba (Azadirachta indica). 
Adathoda vasica has been proved 
hepatoprotective against by D-galactosamine in rats[8] and 
paracetamol induced hepatic damage[9]. Ethyl acetate 
extract of Adhatoda vasica has potent hepatoprotective 
effect against CCl4 - induced liver damage in rats[10-11] and 
in mice too[12]. 
Ethanolic extract of all the parts of Tinospora 
cordifolia showed significant hepatoprotective effect by 
reduction in serum enzymes alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), alkaline 
phosphatase (ALP) and total bilirubin (TBL) in the carbon 
tetrachloride-induced hepatic damage in rats[13]. 
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 Triphala and its constituents show valuable 
hepatoprotective activity. Triphala showed significant 
protection against acute liver toxicity induced by high 
doses of drugs and chemicals, which might be due to high 
levels of phenolic and polyphenolic compounds in these 
plants[14]. 
Terminallia chebulla one of the content of test 
drug was found to prevent the hepatotoxicity caused by 
the ATT15 and significantly reversed the t-BHP-induced cell 
cytotoxicity and lactate dehydrogenase leakage[16]. 
 Another ingredient Azadirachta indica has 
exhibited potent hepatoprotective activity against 
Antitubercular drugs in an experimental study in rats[17] 
and in Paracetamol induced hepatotoxicity in rats on 
biochemical and histologically parameters[18-19]. It also 
showed protective effects against diethyl nitrosamine 
(NDEA) induced hepatotoxicity in male mice[20]. 
Picrorrhiza kurroa possesses potent 
hepatoprotective activity. Its alcoholic, petroleum ether 
and chloroform extract significantly protect hepatic 
damage caused by carbon tetrachloride. In alcohol induced 
hepatotoxicity a significant decline in activities of ALDH is 
seen. Its active principle Picroliv significantly prevents the 
decrease in activities of these enzymes. This result in 
decrease in the generation of free radicals, which lead to 
quicker repair of damaged cell membranes. It also has 
antioxidant activity[21]. Andrographis paniculata has a 
potent hepato-protective action on CCL4 induced hepatic 
damage in rats[22]. 
Thus all the ingredients of test drug have been 
proved as a potent hepatoprotective drug in various in 
vivo and in vitro experimental studies and in some clinical 
studies as well.  
In Ayurvedic perview the ingredients of 
Vasaguduchyadi Kashayam are Tikta (Bitter), Katu 
rasatmak (Pungent), Deepan (stimulators of appetite), 
Pachan (digestive), Raktaprasadak and Shodhana (blood 
purifier) and indicated in the treatment of Pandu, 
Raktapitta and Kamala[7]. It is a Shodhan (mild 
purification) Kalpa and has an affinity to act on Yakrit 
(liver). 
 The properties of Tikta, Katu rasa, Deepan, Pachan 
and Pittashaman render it useful in reducing the 
symptoms of Agnimandya, Aruchi, Hrillas and Trishna as 
they pacify the Doshas and promote Dhatuposhan thus 
reducing Daurbalya and Bhrama. 
The Raktashodhan and Prasadan properties on the 
other hand attribute to the reduction in Nakh-Netra-Twak-
Mala Pitatva. 
The Yakritottejak (hepato-stimulant) and 
Yakritprasadan (hepato-protective) properties of the 
formulation are responsible for the better results in 
alleviation of elevated SGOT, SGPT, Total, Direct& Indirect 
Bilirubin and Alkaline phosphatase. 
CONCLUSION 
 From the above study, an inference can thus be 
drawn that Vasaguduchyadi Kashayam is a herbal 
formulation that effectively reduces the symptoms of 
Agnimandya, Aruchi, Hrillas, Daurbalya and Pitatva 
observed in patients suffering from ALD. It is also effective 
in restoration of normal liver functions and can thus be 
advised as a drug of choice in clinical practice. 
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